Martis Capital
Martis Capital is a healthcare-focused private equity firm investing in middle-market companies across healthcare services, healthcare technology, consumer health, products, diagnostics, and related sectors.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier II
Overview
Martis Capital is a healthcare-focused private equity firm investing in middle-market companies across healthcare services, healthcare technology, consumer health, products, diagnostics, and related sectors.
The firm targets businesses addressing challenges in care delivery, patient access, healthcare operations, and system efficiency. These markets often require investors to understand clinical workflows, payer relationships, regulatory context, technology adoption, and the organizational demands of scaling. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Martis Capital |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | San Francisco, United States |
| Founded | 2011 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier II |
Activities and investment capabilities
Martis emphasizes partnership with founders and management teams. Its flexible approach can support control investments, recapitalizations, and growth situations where existing leaders seek capital and sector-specific resources without losing the operating identity of the business.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Martis Capital fits Tier II because it has developed a visible healthcare franchise, a broad but coherent subsector mandate, and a credible middle-market position supported by dedicated healthcare expertise.
Martis Capital is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Martis Capital is recognized Tier II in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Martis Capital’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Martis Capital as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Martis Capital |
| Headquarters | San Francisco, United States |
| Public website | www.martiscapital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
